Milestone Pharmaceuticals Inc. (MIST): Shareholders' Equity
$41.77M
As of 2025-12-31
$18.22M
As of 2026-06-30
-14.3%
3-year compound annual growth
-21.8%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.77M | +217.7% | 2026-03-20, Balance as of period end |
| 2024-12-31 | $13.15M | -21.6% | 2026-03-20, Balance as of period end |
| 2023-12-31 | $16.77M | -74.7% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $66.35M | -41.1% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $112.60M | -21.3% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $143.12M | +24.5% | 2022-03-24, Balance as of period end |
| 2019-12-31 | $114.92M | +37.5% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $83.55M | n/a | 2020-10-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $41.77M | +217.7% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $51.44M | -67.9% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $98.37M | +14.0% |
| Rezolute, Inc. (RZLT) | 2026-06-30 | $100.69M | -37.9% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $111.38M | -28.5% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $104.71M | -40.5% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $106.63M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
Compare MIST, KRRO, RFL, RZLT side by side · Screen every company in Pharmaceutical Preparations ↗